慢性肾脏病中的维生素D缺乏:迷思还是现实?
结果显示75%患者25(OH)D正常(≥30 ng/mL),仅10%缺乏(<20 ng/mL),与既往文献相反,作者认为可能与补充剂使用史有关,建议补维生素D前先评估25(OH)D状态。
要点
- 南印度3-4期CKD患者中75%的25(OH)D水平正常(≥30 ng/mL)。
- 仅10%患者存在25(OH)D缺乏(<20 ng/mL),15%为不足(20-29 ng/mL)。
- 补维生素D或钙剂前应先检测25(OH)D,以避免高维生素D血症。
核心结论
- 多数南印度3-4期CKD患者25(OH)D水平正常,与既往报道的维生素D缺乏高患病率相反。
主要发现
- 75%患者25(OH)D正常(≥30 ng/mL),15%不足(20-29 ng/mL),10%缺乏(<20 ng/mL)。
- 碱性磷酸酶升高者仅占20%,所有患者血钙正常,5%患者存在高磷血症。
关键数值与推荐
- KDOQI指南建议对血清25(OH)D<30 ng/mL的CKD患者补充维生素D。
- 25(OH)D正常定义为≥30 ng/mL,不足为20-29 ng/mL,缺乏为<20 ng/mL。
临床怎么用
- 给CKD患者处方维生素D或钙剂前,应先检测25(OH)D水平以预防高维生素D血症及其并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Chronic kidney disease (CKD) is a public health problem, which has a prevalence of 17.2% in India. As kidney function decreases, there is a gradual deterioration in the regulation of bone mineral homeostasis. Vitamin D is recognized as the central player in the maintenance of bone health in CKD. Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines suggest that vitamin D supplementation should be given to all CKD patients with serum 25-hydroxy vitaminD (25(OH)D) level < 30 ng/mL. Hence we undertook this study to evaluate the vitamin D status in South Indian patients with CKD. METHODS: Fifty-nine non-dialysis CKD patients of stage 3 and 4 were recruited and screened for 25(OH)D deficiency. Circulating levels of 25(OH)D were measured using chemiluminescence immunoassay. The estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology (CKD-EPI) equation. Serum calcium, phosphorous, creatinine and alkaline phosphatase levels were measured spectrophotometrically by an autoanalyzer. RESULTS: Contrary to published literature, 75% of South Indian CKD patients had normal 25(OH)D (≥30 ng/mL), 15% of them had insufficient (20-29 ng/mL) and 10% had 25(OH)D deficiency (<20 ng/mL). Alkaline phosphatase levels were found to be increased in only 20% of cases. Calcium1 levels were normal in all CKD cases and hyperphosphatemia was observed in 5% of CKD patients. CONCLUSION: We found that most of our CKD patients (75%) had normal vitamin D levels. This paradoxical finding could be explained by the fact that most of them gave a history of intake of vitamin D and calcium supplements, as advised by their doctors before coming to our institute. Hence we conclude that before prescribing vitamin D or calcium supplements to CKD patients, their 25(OH)D status should be ascertained to prevent hypervitaminosis D and its complications.
引用
- Priyadarshini G, Parameswaran S, Sahoo J, et al. Vitamin D deficiency in chronic kidney disease: Myth or reality? Clin Chim Acta. 2021. PMID: 34480954. doi:10.1016/j.cca.2021.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。